BioSpace News Archive

Vir Biotechnology, Inc. announced that George Scangos, Ph.D., Chief Executive Officer will present at the 40th Annual Cowen Healthcare Conference on Tuesday, March 3rd at 11:20 a.m. ET.

Shuwen Biotech Co. Ltd., a China-based leader in innovative diagnostics announced that PerkinElmer, Inc. will distribute Shuwen’s breakthrough diagnostic test for preeclampsia in over 100 countries around the globe, accounting for over 120 million pregnancies annually.

ALACHUA, Fla., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the fourth quarter and full year ended December 31, 2019. Fourth Quarter 2019 Financial Results and Business Highlights Net sales were $28.1 million during the quarter, an increase of 20% compared to fourth quarter 2018 revenue of $23.4 million. G

Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that updated data from the Phase 2 PIONEER trial of avapritinib

Researchers at the University of Texas at Austin and the National Institutes of Health created the first 3D atomic scale map of the 2019 novel coronavirus.

Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology pioneer focused on innovative aesthetic and therapeutic offerings, including its next-generation neuromodulator product, DaxibotulinumtoxinA for Injection (DAXI), today reported financial results for the fourth quarter and full year ended December 31, 2019, and provided a corporate update.

BEDMINSTER, N.J., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (“Matinas BioPharma” or the “Company”) -- (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company, today announced that the Company will host a conference call and live audio webcast on Monday, March 9, 2020 at 8:00 a.m. ET to discuss operational and financial results for the fourth quarter and full year ended December 31, 2019. To participate in the call, please dial (877) 407-5976 (domestic) or (412)

PRINCETON, N.J., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq:IART), a leading global medical technology company, today announced the launch of AmnioExcel ® Plus Placental Allograft Membrane, its latest wound care offering to support soft tissue repair. AmnioExcel Plus is a next generation, thicker, tri-layer, non-side specific allograft consisting of amnion-chorion-amnion layers that aids in creating an environment to help close complex wounds. The pro

A new study marks a significant advance in developing a gene therapy for X-linked retinitis pigmentosa, a hereditary disease that leads to severe sight loss in young males.

Feb. 24, 2020 21:15 UTC Tricida to Present at the Cowen 40 th Annual Health Care Conference SOUTH SAN FRANCISCO, Calif.--( BUSINESS WIRE )-- Tricida, Inc. (Nasdaq: TCDA) today announced that it will present at the Cowen 40 th Annual Health Care Conference on Monday, March 2, 2020 at 11:10 am PT / 2:10 pm ET. Geoff Parker, Tricida’s Chief Financial Officer, will provide a company overview, business update and progress on the company’s key initiatives. A live webcast of the pr